NCT04746638View on ClinicalTrials.gov

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 19, 2022

Study Completion Date

June 1, 2023

Conditions
Prostate CancerBreast Cancer Female
Interventions
DIAGNOSTIC_TEST

whole body study and SPECT with 99mTc-RM26

One single intravenous injection of 99mTc-RM26, followed by gamma camera imaging after 2, 4, 6 and 24 hours.

Trial Locations (1)

Unknown

TomskNRMC, Tomsk

All Listed Sponsors
collaborator

Uppsala University

OTHER

lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT04746638 - Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26 | Biotech Hunter | Biotech Hunter